FBTDX
FSS FR Bio-Tech Discovery Cl C
$165.57
FSS FR Bio-Tech Discovery Cl C (FBTDX)
FBTDX is a mutual fund that focuses on investing in the biotechnology sector. It seeks to discover and capitalize on emerging companies in the field of biotechnology, with a particular focus on those involved in research and development of new drugs and treatments. This fund, managed by FSS Investment Management, aims to provide long-term growth and capital appreciation for its investors through a diversified portfolio of biotech companies. As a Class C fund, it may have a higher expense ratio but also offers potential for higher returns.
FBTDX Mutual Fund Chart & Stats
$165.57
At close: 4:00 PM EST- Previous Close
- $165.57
- Sub-Category
- Sector-Specific
- Total Liabilities
- $37.83M
- Expense Ratio
- 1.76%
- Holding Count
- 108
- Brand
- Franklin Strategic Series
- Category
- Equity
- Total Assets
- 1.19B
- Shares Outstanding
- N/A
- 52-Week Range
- $142.37 - $189.31
FBTDX Mutual Fund News
FBTDX Mutual Fund Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| JAZZJazz Pharmaceuticals | 5.66% |
| AMGNAmgen Inc | 4.39% |
| GILDGilead Sciences | 3.86% |
| REGNRegeneron Pharmaceuticals | 3.77% |
| ARGXArgenx | 3.62% |
| VRTXVertex Pharmaceuticals Inc. | 3.54% |
| USD_CASHFranklin Institutional U.S. Government Money Market Fund | 3.18% |
| RVMDRevolution Medicines, Inc. | 3.01% |
| GHGuardant Health | 2.76% |
| ASNDAscendis Pharma A/S | 2.56% |
| Total | 36.34% |
Recently Viewed
No data currently available






